Investigating the Impact of METTL3 on Reinforcing Cell Adhesion by Enhancing Immunity through m6A-Mediated Stabilization of Integrin β1 mRNA in Osteosarcoma
Osteosarcoma, a prevalent primary malignancy, continues to present significant challenges for current treatment strategies. However, a promising breakthrough emerges with PR-619, a novel inhibitor of deubiquitinating enzymes, showcasing remarkable anti-tumor effectiveness across various cancers. Recent advances in N6-m...